Related Experiment Video
Updated: Jul 14, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
C-reactive protein and heart failure after myocardial infarction in the community
Francesca Bursi1, Susan A Weston, Jill M Killian
1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn 55901, USA.
Insights
High C-reactive protein (CRP) levels after myocardial infarction predict increased risk for heart failure and death. This inflammatory marker offers prognostic value independent of traditional risk factors in post-MI patients.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- Limited data exists on C-reactive protein's (CRP) prognostic role post-myocardial infarction (MI).
- Community-based studies on CRP and post-MI outcomes are scarce.
Purpose of the Study:
- To prospectively investigate the association between CRP levels and the risk of heart failure and death after MI.
- To determine if CRP provides prognostic information beyond established risk factors.
Main Methods:
- Prospective enrollment of 329 community patients with MI.
- Measurement of CRP on admission and follow-up for heart failure and mortality.
- Statistical analysis to assess the association between CRP tertiles and outcomes, adjusting for covariates.
Main Results:
- At one year, 28% experienced heart failure and 20% died.
- A significant graded association was observed between CRP levels and increased risk of heart failure and death (P < .001).
- Patients in the highest CRP tertile had significantly higher risks for heart failure (aHR 2.47) and death (aHR 3.96) compared to the lowest tertile, independent of other factors.
Conclusions:
- Heart failure and death are frequent complications following MI in community settings.
- Elevated CRP levels are strongly associated with increased risk of heart failure and death post-MI.
- Inflammation, as indicated by CRP, may play a significant role in post-MI complications, independent of conventional prognosticators.
Background:
There is a paucity of data on the prognostic role of C-reactive protein (CRP) measured after myocardial infarction. We prospectively examined the association of CRP with heart failure and death among patients with myocardial infarction in the community.
Methods And Results:
All Olmsted County residents who had a myocardial infarction meeting standardized criteria were prospectively enrolled to measure CRP on admission and followed for heart failure and death. A total of 329 consecutive patients (mean age 69 +/- 16 years, 52% men) were enrolled. At 1 year, 28% of patients experienced heart failure and 20% died. There was a strong positive graded association between CRP and the risk of developing heart failure, as well as dying over the period of follow-up (P < .001). Compared with patients in the first tertile, patients in the third tertile of the CRP distribution had a markedly increased risk of heart failure and death independently of age, sex, troponin T, Q wave, comorbidity, previous myocardial infarction, and recurrent ischemic events (adjusted hazard ratio 2.47 [95% confidence interval, 1.27-4.82] for heart failure and 3.96 [95% confidence interval, 1.78-8.83] for death).
Conclusions:
These prospective data indicate that among contemporary community subjects with myocardial infarction, heart failure and death remain frequent complications. CRP is associated with a large increase in the risk of heart failure and death, independently of age, sex, myocardial infarction severity, comorbidity, previous myocardial infarction, and recurrent ischemic events. These data suggest that inflammatory processes may play a role in the development of heart failure and death after myocardial infarction independently of other conventional prognostic indicators.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease IV: Nursing Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies